TrialBritish journal of cancer2025

Radiotherapy combined with anlotinib in locoregional recurrent esophageal squamous cell carcinoma after radical surgery: a prospective, Phase II clinical trial.

Chengcheng Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.